Nightingale Health partners with Archipelago Health to roll out blood-test screening in Crown Dependencies, Bermuda, Caribbean

By Public Technologies
  • Nightingale Health signed an agreement with Archipelago Health to roll out the Nightingale Health Check across the Crown Dependencies, Bermuda, the Caribbean.
  • Archipelago will market the test under its Longitude brand through existing primary care networks; Nightingale will analyze samples.
  • Launch planned for November 2026, starting in Jersey.
  • Service uses standard venous blood draws or finger-prick dried blood spots to support remote or workplace collection.
  • Test generates 10-year risk scores for major chronic diseases, positioning the partners for prevention-led screening in small-island health systems.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nightingale Health Oyj published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.